https://pubmed.ncbi.nlm.nih.gov/35762577/
Evolution-based mathematical models significantly prolong response to abiraterone in metastatic...
Moffitt internal grants and NIH/NCI U54CA143970-05 (Physical Science Oncology Network).
mathematical modelsevolutionbasedsignificantly
https://pubmed.ncbi.nlm.nih.gov/38622681/
Polymorphic ventricular tachycardia and cardiac arrest from abiraterone-induced hypokalemia: a case...
A broad differential diagnosis for polymorphic ventricular tachycardia is essential in identifying and treating patients presenting in this rhythm. Here we...
ventricular tachycardiacardiac arrest
https://adisinsight.springer.com/trials/700259844?error=cookies_not_supported&code=98b58a3c-ae9b-40fd-a7bc-2a5bc7e7f761
Withdrawal responses to abiraterone acetate on prostate specific antigen declines in patients with...
This study investigated the effect of abiraterone acetate discontinuation on incidence and duration of prostate-specific antigen (PSA) declines in CRPC
prostate specific antigen
https://ctgate.cci.fsu.edu/value-of-treatment-in-clinical-trials-versus-the-real-world-the-case-of-abiraterone-acetate-zytiga-for-postchemotherapy-metastatic-castration-resistant-prostate-cancer-patients-in-sweden/
Value of treatment in clinical trials versus the real world: the case of abiraterone acetate...
Title : Value of treatment in clinical trials versus the real world: the case of abiraterone acetate (Zytiga) for postchemotherapy metastatic...
the real world
https://www.jnj.com/media-center/press-releases/abiraterone-acetate-provided-significant-clinical-benefit-in-patients-with-high-risk-metastatic-hormone-naive-prostate-cancer-mhnpc-improving-overall-survival-and-radiographic-progression-free-survival
Abiraterone Acetate Provided Significant Clinical Benefit in Patients with High-Risk Metastatic...
abiraterone acetate
https://pubmed.ncbi.nlm.nih.gov/22995653/?dopt=Abstract
Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall...
This final analysis confirms that abiraterone acetate significantly prolongs overall survival in patients with metastatic castration-resistant prostate cancer...
abiraterone acetate
https://scholars.duke.edu/publication/1481831
Scholars@Duke publication: A prospective trial of abiraterone acetate plus prednisone in Black and...
https://pubmed.ncbi.nlm.nih.gov/21612468/
Abiraterone and increased survival in metastatic prostate cancer
The inhibition of androgen biosynthesis by abiraterone acetate prolonged overall survival among patients with metastatic castration-resistant prostate cancer...
abirateroneincreasedsurvivalmetastaticprostate
https://myhealth.alberta.ca/Health/medications/Pages/conditions.aspx?hwid=fdb1414
Abiraterone - Oral
abirateroneoral
https://pure.psu.edu/en/publications/investigating-the-usage-of-abiraterone-in-african-american-men-wi/
Investigating the Usage of Abiraterone in African American Men with Metastatic Prostate Cancer -...
https://research.birmingham.ac.uk/en/publications/abiraterone-for-prostate-cancer-not-previously-treated-with-hormo/
Abiraterone for prostate cancer not previously treated with hormone therapy - University of...
prostate cancer
https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-looking-abiraterone-with-exemestane-for-breast-cancer-that-has-spread
A trial looking at abiraterone with exemestane for breast cancer that has spread
This trial is looking at using a new drug called abiraterone with exemestane for breast cancer that has spread to another part of the body.
https://op.europa.eu/en/web/public-procurement/procurement-details/-/procurement/9d5fd01c-346b-429f-8474-3053a0f9724e
The drug abiraterone - extreme urgency - EU tenders - Publications Office of the EU
eu tenderspublications officedrugabirateroneextreme
https://pubmed.ncbi.nlm.nih.gov/25184630/
AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer
Detection of AR-V7 in circulating tumor cells from patients with castration-resistant prostate cancer may be associated with resistance to enzalutamide and...
arresistanceenzalutamideabirateroneprostate
https://seer.cancer.gov/oncologytoolbox/canmed/ndconc/82293-0002/
82293-0002 Abiraterone Acetate - CanMED: NDC
CanMED: NDC. The Cancer Medications Enquiry Database (CanMED) is a two-part resource for cancer drug treatment related studies.
abiraterone acetatendc
https://pubmed.ncbi.nlm.nih.gov/28426121/
Phase II study of cabazitaxel with or without abiraterone acetate and prednisone in patients with...
Phase II study of cabazitaxel with or without abiraterone acetate and prednisone in patients with metastatic castrate resistant prostate cancer after prior...
https://adisinsight.springer.com/drugsafety/803381836?error=cookies_not_supported&code=a334b9b7-a849-4fe8-9b60-69200665dc0f
Abiraterone acetate/enzalutamide - AdisInsight
A man in his early 60s [exact age at the time of reaction onset not stated] developed spinal epidural lipomatosis following treatment with abiraterone acetate
abiraterone acetateenzalutamideadisinsight
https://www.cochrane.org/ms/evidence/CD013245_adding-abiraterone-acetate-androgen-deprivation-therapy-treatment-metastatic-hormone-sensitive
Penambahan abiraterone asetat ke dalam terapi kekurangan androgen untuk rawatan barah prostat...
https://experts.umn.edu/en/publications/combining-polyadp-ribose-polymerase-inhibitors-with-abiraterone-i/
Combining Poly(ADP)-Ribose Polymerase Inhibitors With Abiraterone in Castration-Resistant Prostate...
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/abiraterone-acetate
Definition of abiraterone acetate - NCI Dictionary of Cancer Terms - NCI
NCI's Dictionary of Cancer Terms provides easy-to-understand definitions for words and phrases related to cancer and medicine.
definition ofabiraterone acetatencidictionarycancer
https://adisinsight.springer.com/drugsafety/803608878?error=cookies_not_supported&code=c0222666-bc53-45fd-a05e-344195a51b79
Abiraterone/denosumab/rosuvastatin - AdisInsight
An 89-year-old man developed rhabdomyolysis following interaction between abiraterone, rosuvastatin and denosumab [not all dosages and routes stated].The man
abirateronedenosumabrosuvastatinadisinsight
https://experts.umn.edu/en/publications/abiraterone-acetate-for-the-treatment-of-prostate-cancer/
Abiraterone acetate for the treatment of prostate cancer - Experts@Minnesota
abiraterone acetatefor theprostate cancertreatmentexperts
https://www.mdpi.com/1718-7729/32/3/156
Adrenal Insufficiency Induced by Continued Abiraterone Acetate Use in a Prostate Cancer Patient in...
This case report presents a rare occurrence of adrenal insufficiency induced by Zytiga (abiraterone acetate) in a patient with high-risk localized prostatic...
https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-niraparib-and-abiraterone-acetate-plus-prednisone-brca2-mutated-metastatic-castration
FDA approves niraparib and abiraterone acetate plus prednisone for BRCA2-mutated metastatic...
On December 12, 2025, the Food and Drug Administration approved niraparib and abiraterone acetate (Akeega, Janssen Biotech, Inc.) with prednisone for adults...
fda approvesabiraterone acetate
https://pubmed.ncbi.nlm.nih.gov/27223078/
Predictors of long-term response to abiraterone in patients with metastastic castration-resistant...
https://scholars.okstate.edu/en/publications/assessing-patient-risk-benefit-and-outcomes-in-drug-development-a-9/fingerprints/
Assessing Patient Risk, Benefit, and Outcomes in Drug Development: A Decade of Abiraterone Clinical...
https://pubmed.ncbi.nlm.nih.gov/33259932/
Combination of Radiation Therapy and Short-Term Androgen Blockade With Abiraterone Acetate Plus...
The combination of RT and 6 months of ADT and AAP demonstrated acceptable toxicity and a high rate of testosterone recovery with restoration of quality of life...
https://www.sciencedaily.com/releases/2012/01/120106110546.htm
Abiraterone for prostate cancer: Indication of considerable added benefit in certain patients |...
Abiraterone acetate is approved for treatment of metastatic prostate cancer that can no longer be treated with hormones and progresses further during or after...
prostate cancer
https://pubmed.ncbi.nlm.nih.gov/33705584/
Safety of concomitant therapy with radium-223 and abiraterone or enzalutamide in a real-world...
Despite the common use of concomitant therapy in this real-world study, there was no difference in OS among mCRPC patients. A nonsignificant increased SRE risk...
https://www.cancer.gov/about-cancer/treatment/drugs/niraparib-tosylate-monohydrate-and-abiraterone-acetate
Niraparib Tosylate Monohydrate and Abiraterone Acetate - NCI
This page contains brief information about niraparib tosylate monohydrate and abiraterone acetate and a collection of links to more information about the use...
abiraterone acetateniraparibmonohydratenci
https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2020.00495/full
Frontiers | Abiraterone Rechallenge Based on Sequential Testing of Androgen Receptor Splice Variant...
Serial analysis of circulating tumor cells such as androgen receptor splice variant 7 is useful in selecting treatments for castration-resistant prostate can...
based on
https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-looking-at-olaparib-and-abiraterone-for-prostate-cancer-propel
A trial looking at olaparib and abiraterone for prostate cancer (PROpel)
This trial is for people with prostate cancer that has spread and got worse despite having hormone treatment.
looking atprostate cancertrialolaparib
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9ce9d926-ef3a-4b22-a703-f49c18eb4e3d&audience=consumer
DailyMed - ABIRATERONE ACETATE tablet, film coated
abiraterone acetatedailymedtabletfilmcoated
https://adisinsight.springer.com/drugsafety/803929465?error=cookies_not_supported&code=42c5b1e1-b472-4b50-8828-860773838c64
Abiraterone - AdisInsight
An 85-year-old man with metastatic prostate cancer receiving abiraterone experienced mineralocorticoid excess syndrome with hypokalaemia, rhabdomyolysis and
abirateroneadisinsight
https://ce.icep.wisc.edu/human-oncology-journal-club-2020-22-/content/abiraterone-acetate-and-prednisolone-or-without-enzalutamide-high-risk-non-metastatic
Abiraterone Acetate and Prednisolone with or without Enzalutamide for High-Risk Non-Metastatic...
EvaluationClick here to complete the evaluation: https://ce.icep.wisc.edu/content/human-oncology-journal-club-2020-22-evaluation-18998
https://news.cancerresearchuk.org/2017/06/03/adding-abiraterone-to-standard-treatment-improves-prostate-cancer-survival-by-40-per-cent/
Adding abiraterone to standard treatment improves prostate cancer survival by 40 per cent - Cancer...
Jul 20, 2021 - Adding abiraterone to hormone therapy at the start of treatment for prostate cancer improves survival by 37 per cent.
https://yoda.yale.edu/clinical-trial/nct00887198-a-phase-3-randomized-double-blind-placebo-controlled-study-of-abiraterone-acetate-cb7630-plus-prednisone-in-asymptomatic-or-mildly-symptomatic-patients-with-metastatic-castration-re/
NCT00887198 - A Phase 3, Randomized, Double-blind, Placebo-Controlled Study of Abiraterone Acetate...
https://adisinsight.springer.com/trials/700307093?error=cookies_not_supported&code=e622a83c-91d8-449c-b8d1-82cf70b6094d
A real-world, retrospective, observational study of Abiraterone acetate plus prednisone for the...
The purpose of this real world study is to evaluate the efficacy of abiraterone acetate plus prednisone or corticosteroid in patients with metastatic castration
https://www.fda.gov/drugs/resources-information-approved-drugs/fda-disco-burst-edition-fda-approval-lynparza-olaparib-abiraterone-and-prednisone-brca-mutated
FDA D.I.S.C.O. Burst Edition: FDA approval of Lynparza (olaparib), with abiraterone and prednisone,...
Listen to a soundcast of the May 31, 2023, FDA approval of Lynparza (olaparib), with abiraterone and prednisone, for BRCA-mutated metastatic...
https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/trial-idasanutlin-abiraterone-enzalutamide-prostate-cancer-spread-madcap
A trial of idasanutlin with abiraterone or enzalutamide for prostate cancer that has spread (MAdCaP)
This trial looked at idasanutlin for prostate cancer that was no longer responding to hormone therapy and had spread to another part of the body.
https://adisinsight.springer.com/drugsafety/803929094?error=cookies_not_supported&code=05a79cc8-58f3-40cd-a679-b9e2d60577d1
Abiraterone - AdisInsight
A 70-year-old man with high-risk localised prostate cancer and no reported comorbidities experienced difficult-to-control hypertension while being treated with
abirateroneadisinsight